A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer

por Mitchell, Paul LR, Quinn, Michael A, Grant, Peter T, Allen, David G, Jobling, Thomas W, White, Shane C, Zhao, Anne, Karanikas, Vaios, Vaughan, Hilary, Pietersz, Geoffrey, McKenzie, Ian FC, Gargosky, Sharron E, Loveland, Bruce E
Publicado 2014

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial

por Gray, H. J., Benigno, B., Berek, J., Chang, J., Mason, J., Mileshkin, L., Mitchell, P., Moradi, M., Recio, F. O., Michener, C. M., Secord, A. Alvarez, Tchabo, N E., Chan, J. K., Young, J., Kohrt, H., Gargosky, S. E., Goh, J. C.
Publicado 2016